department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Allegra · pharmadog

pharmadog
drugs
Allegra

drug

patient view →

fexofenadine hydrochloride

Marketedupdated 2mo ago

by Chattem Inc

Approved

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 2 investigational indications.

all catalysts(1)

approval · 1

FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE) — FDA approval

fexofenadine hydrochloride

News(0)

no news has mentioned this drug yet

brand

Allegra

generic

fexofenadine hydrochloride

MOA

Histamine H1 receptor antagonist

indication

Chronic Urticaria

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Aug 2, 2030

~4.1 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

Aug 2, 2030formulationUS 89330974.1y
Aug 2, 2030formulationUS 89330974.1y

$PRGO11.12+0.94%

🐶 often sniffed alongside

top 7

drugFEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE13 co-mentions · 4 sources
tagApproval12 co-mentions · 3 sources
tagSmall Molecule6 co-mentions · 3 sources
company$PRGOPERRIGO Co plc2 co-mentions · 1 sources
drugpseudoephedrine hydrochloride ER2 co-mentions · 1 sources
drugPSEUDOEPHEDRINE HYDROCHLORIDE2 co-mentions · 1 sources
companyNorthwestern University1 co-mentions · 1 sources

Trials studying fexofenadine hydrochloride

N/AInvestigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesissuspendedn=177
N/AInvestigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesiscompletedn=137
phase1Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgcompletedn=28
phase1Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgcompletedn=68
N/AAll Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valveunknownn=130